HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rehan Ahmad Selected Research

Oncogene Proteins (Oncogene Protein)

12/2016MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway.
5/2014Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells.
10/2013MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells.
11/2012MUC1-C oncoprotein confers androgen-independent growth of human prostate cancer cells.
5/2012Targeting cysteine-mediated dimerization of the MUC1-C oncoprotein in human cancer cells.
3/2012MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells.
9/2011Androgen receptor regulates expression of the MUC1-C oncoprotein in human prostate cancer cells.
5/2011Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells.
1/2011MUC1-C oncoprotein regulates glycolysis and pyruvate kinase M2 activity in cancer cells.
9/2010Terminal differentiation of chronic myelogenous leukemia cells is induced by targeting of the MUC1-C oncoprotein.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rehan Ahmad Research Topics

Disease

30Neoplasms (Cancer)
06/2022 - 11/2006
14Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 03/2016
9Breast Neoplasms (Breast Cancer)
01/2022 - 06/2009
9Carcinoma (Carcinomatosis)
03/2015 - 08/2006
5Colonic Neoplasms (Colon Cancer)
06/2022 - 01/2017
5Prostatic Neoplasms (Prostate Cancer)
01/2022 - 11/2009
5Necrosis
10/2019 - 11/2006
3Triple Negative Breast Neoplasms
01/2022 - 12/2016
2Carcinogenesis
07/2016 - 02/2016
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2015 - 05/2011
2Multiple Myeloma
08/2010 - 07/2008
1Hypertensive Crisis
07/2022
1Inflammation (Inflammations)
01/2021
1Osteoporosis
01/2021
1Adenocarcinoma
01/2020
1Neoplasm Metastasis (Metastasis)
01/2018
1Lymphatic Metastasis
06/2017
1Diabetic Retinopathy (Retinopathy, Diabetic)
06/2015
1Neurodegenerative Diseases (Neurodegenerative Disease)
06/2015
1Fowlpox
09/2012
1Hematologic Neoplasms (Hematological Malignancy)
12/2011
1Congenital Heart Defects (Congenital Heart Defect)
10/2011
1Cardiomyopathies (Cardiomyopathy)
10/2011

Drug/Important Bio-Agent (IBA)

19Oncogene Proteins (Oncogene Protein)IBA
12/2016 - 08/2006
16Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2010
10Mucin-1 (CA 15-3 Antigen)IBA
07/2016 - 06/2009
5NF-kappa B (NF-kB)IBA
08/2010 - 11/2006
4Antineoplastic Agents (Antineoplastics)IBA
06/2022 - 01/2018
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 05/2011
3Glycoproteins (Glycoprotein)IBA
01/2022 - 01/2011
3Biomarkers (Surrogate Marker)IBA
06/2017 - 12/2011
3Messenger RNA (mRNA)IBA
06/2017 - 01/2010
3(arginine)9- cysteinyl- glutaminyl- cysteinyl- arginyl- arginyl- lysyl- asparagineIBA
01/2017 - 05/2011
3GO 201IBA
09/2010 - 06/2009
3TriterpenesIBA
07/2010 - 11/2006
3EstersIBA
07/2010 - 11/2006
3bardoxolone methylIBA
07/2010 - 11/2006
2PolyphenolsIBA
01/2021 - 01/2021
2PlatinumIBA
09/2020 - 07/2020
2Phosphotransferases (Kinase)IBA
07/2020 - 02/2011
2Cytochromes c (Cytochrome c)IBA
07/2020 - 01/2017
2Pharmaceutical PreparationsIBA
01/2020 - 12/2011
2Cysteine (L-Cysteine)FDA Link
10/2019 - 05/2012
2SulfonamidesIBA
10/2019 - 01/2018
2Peptides (Polypeptides)IBA
01/2017 - 08/2010
2MicroRNAs (MicroRNA)IBA
03/2015 - 01/2010
2AndrogensIBA
11/2012 - 09/2011
2Androgen Receptors (Androgen Receptor)IBA
09/2011 - 11/2009
2STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
02/2011 - 07/2010
2AcidsIBA
04/2008 - 11/2006
1Labetalol (Normodyne)FDA LinkGeneric
07/2022
1Nitroglycerin (Dynamite)FDA LinkGeneric
07/2022
1ThiosemicarbazonesIBA
06/2022
1Irinotecan (Camptosar)FDA LinkGeneric
01/2022
1IsatinIBA
12/2021
1Fluorouracil (Carac)FDA LinkGeneric
12/2021
1benzofuranIBA
12/2021
13,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneIBA
01/2021
1sulfoenolpyruvateIBA
01/2021
1Fatty Acids (Saturated Fatty Acids)IBA
01/2021
1PolyaminesIBA
01/2021
1VitaminsIBA
01/2021
1E2F1 Transcription FactorIBA
01/2021
1Small Interfering RNA (siRNA)IBA
07/2020
1Glutathione (Reduced Glutathione)IBA
07/2020
1Melanins (Melanin)IBA
01/2020
1Transcription Factors (Transcription Factor)IBA
10/2019
1QuinazolinesIBA
01/2018
1Tumor Biomarkers (Tumor Markers)IBA
06/2017
1Caspase 3 (Caspase-3)IBA
01/2017
1MetalsIBA
01/2017
1Caspase 9IBA
01/2017
1Mucin 5ACIBA
07/2016
1MucinsIBA
07/2016
1AntibodiesIBA
07/2016
1ParaffinIBA
07/2016
1Formaldehyde (Formol)FDA Link
07/2016
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
02/2016
1chetominIBA
02/2016
1Protein Isoforms (Isoforms)IBA
02/2016
1Rutin (Rutoside)IBA
06/2015
1FlavonoidsIBA
06/2015
1AntioxidantsIBA
06/2015
1Retinaldehyde (Retinal)IBA
06/2015
1RNA-Binding Proteins (RNA-Binding Protein)IBA
03/2015
1Phenobarbital (Luminal)FDA Link
05/2014
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2013
1Aldehyde DehydrogenaseIBA
10/2013
1Carcinoembryonic AntigenIBA
09/2012
1AntigensIBA
09/2012
1Cancer VaccinesIBA
09/2012
1DNA (Deoxyribonucleic Acid)IBA
06/2012
1Cell-Penetrating PeptidesIBA
05/2012
1Reducing AgentsIBA
05/2012
1DisulfidesIBA
05/2012
1Cyclin D1IBA
03/2012
1Transcription Factor 7-Like 2 ProteinIBA
03/2012
1Cytidine Monophosphate (CMP)IBA
10/2011

Therapy/Procedure

4Therapeutics
01/2021 - 03/2016
1Drug Therapy (Chemotherapy)
01/2020